Detalles de la búsqueda
1.
Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study.
Diabetes Obes Metab
; 25(6): 1758-1768, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843215
2.
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
Diabetes Obes Metab
; 23(8): 1851-1858, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33908691
3.
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials.
Diabetes Obes Metab
; 23(8): 1961-1967, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33908683
4.
Effect of once-weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial.
Diabetes Obes Metab
; 22(12): 2493-2498, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803900
5.
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.
Diabetes Obes Metab
; 22(9): 1556-1566, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32329160
6.
Kidney and heart failure outcomes associated with SGLT2 inhibitor use.
Nat Rev Nephrol
; 18(5): 294-306, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145275
7.
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.
Clin Pharmacokinet
; 60(4): 517-525, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587286
8.
Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasma and urine.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1152: 122257, 2020 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663790
9.
Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice.
Nat Rev Nephrol
; 16(8): 433-434, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32541904
Resultados
1 -
9
de 9
1
Próxima >
>>